Under the agreement, Shenzhen Kangtai, one of China’s top vaccine makers, will ensure it has annual production capacity of at least 100 million doses of the experimental shot AZD1222 by the end of this year.
from Hindustan Times - world https://ift.tt/3l2PyGv
No comments:
Post a Comment